140.00↑2.10 (1.52%)
04:01 PM,4th Dec 2023BSE : 531569
NSE :
Sector : Health care
ISIN Code : INE860D01013
Last Updated: Dec 04 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.Incorporated as a public limited company in Oct.'94 Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Company's products includes oral solids small volume parenteral and sterile powder formulations.The company is setting up a plant at Taloja Maharashtra to manufacture high grade anti-biotics and life saving injectibles used in various infections pre- and post-operative. The installed capacities for its products will be 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project.The promoters have received firm inquiries from reputed pharmaceutical companies like Merind Lupin Laboratories and USV for the first year' production of liquid vials and ampules.During the year 1998-99 the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa Europe & Latin America. The Company has also tied up with Cadila Ltd. Alkem Ltd. Indian Immunologicals Ltd for marketing its products.During the year 1999-2000 the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.During 2009 the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 140 |
EPS - TTM (₹) [S] | 5.21 |
P/E Ratio (X) [S] | 777.78 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 0.18 |
P/B Ratio (₹) [S] | 777.78 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 135.20 140.00 |
Week Low/High | 132.55 140.00 |
Month Low/High | 124.45 148.00 |
Year Low/High | 24.80 148.00 |
All time Low/High | 1.76 148.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -0.18% | % | 4.39 | 4.51% |
1 Month | 12.36% | % | 6.99 | 7.57% |
3 Month | 50.81% | % | 4.93 | 5.93% |
6 Month | 111.35% | % | 10.10 | 11.61% |
1 Year | 245.25% | % | 9.54 | 10.65% |
3 Year | % | % | 52.76 | 56.03% |
Chairman & Managing Director : Ashwin Khemka
Independent Director : Mrunmai M Sarvankar
Independent Director : Shrenikkumar P Solanki
Independent Director : Monika Singhania
Director : Srivardhan Ashwani Khemka
Company Sec. & Compli. Officer : Ritu Puglia
Registered Office: 205 P N Khotari Indl Estate, LBS Marg Bhandup (West),Mumbai,Maharashtra-400078 Ph: 91-22-67290900
Email:info@sanjivani.co.in